Literature DB >> 6729810

A successful trial of enzyme replacement therapy in a case of argininemia.

T Sakiyama, H Nakabayashi, H Shimizu, W Kondo, S Kodama, T Kitagawa.   

Abstract

A 5-year-old boy with severe mental retardation and spastic quadriplegia accompanied by tonic seizures and hyperammonemia was diagnosed as having argininemia due to an arginase deficiency in his erythrocytes. His motor and mental abilities began to deteriorate at the age of 3 years. Thereafter, he lost his ability to stand alone, to sit and even to crawl by himself. After he was diagnosed as argininemia , a protein restricted diet was given as therapy, which was accompanied with a supplement of essential amino acids. However, his clinical condition had not improved very much. The erythrocytes in a normal person was found to have the ability to decrease the patient's elevated plasma arginine level to normal when they are mixed in vitro. First we tried replacing his red cells by a blood transfusion. Then we replaced them with the aid of an IBM 2997 blood cell separator. Following this his clinical and biochemical condition improved, and as a result so did his sitting and crawling abilities. It appears that the replacement of red blood cells improves not only the clinical and biochemical conditions, but the general condition of the patient as well.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6729810     DOI: 10.1620/tjem.142.239

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  7 in total

Review 1.  Enzyme-replacement therapy: problems and prospects.

Authors:  B Rademaker; J Raber
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

2.  SCHEMA-designed variants of human Arginase I and II reveal sequence elements important to stability and catalysis.

Authors:  Philip A Romero; Everett Stone; Candice Lamb; Lynne Chantranupong; Andreas Krause; Aleksandr E Miklos; Randall A Hughes; Blake Fechtel; Andrew D Ellington; Frances H Arnold; George Georgiou
Journal:  ACS Synth Biol       Date:  2012-06-15       Impact factor: 5.110

Review 3.  Arginase-1 deficiency.

Authors:  Yuan Yan Sin; Garrett Baron; Andreas Schulze; Colin D Funk
Journal:  J Mol Med (Berl)       Date:  2015-10-14       Impact factor: 4.599

4.  Arginase I mRNA therapy - a novel approach to rescue arginase 1 enzyme deficiency.

Authors:  Kirtika H Asrani; Lei Cheng; Christopher J Cheng; Romesh R Subramanian
Journal:  RNA Biol       Date:  2018-07-24       Impact factor: 4.652

5.  Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency.

Authors:  Lindsay C Burrage; Qin Sun; Sarah H Elsea; Ming-Ming Jiang; Sandesh C S Nagamani; Arthur E Frankel; Everett Stone; Susan E Alters; Dale E Johnson; Scott W Rowlinson; George Georgiou; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2015-09-10       Impact factor: 6.150

Review 6.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

7.  Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency.

Authors:  George A Diaz; Andreas Schulze; Markey C McNutt; Elisa Leão-Teles; J Lawrence Merritt; Gregory M Enns; Spyros Batzios; Allison Bannick; Roberto T Zori; Leslie S Sloan; Susan L Potts; Gillian Bubb; Anthony G Quinn
Journal:  J Inherit Metab Dis       Date:  2021-01-26       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.